Device / Technology News

RSS

Freedom Innovations announces license agreement for lower extremity prosthesis

Freedom Innovations, a company that specializes in the development of high technology lower extremity prosthetic devices, today announced a worldwide licensing agreement. The agreement grants the company exclusive rights to commercialize the world's first lower extremity prosthesis with actively powered knee and ankle joints that operate synergistically.

From PROTEOR 15 Apr 2011

Researchers develop Short-CGH method for preimplantation genetic screening

A Short Comparative Genomic Hybridisation method has been developed to carry out preimplantation genetic screening by analysing all chromosomes and transferring selected embryos to the recipient uterus in the same in vitro fertilisation cycle. This eliminates the need to freeze them.

15 Apr 2011

Researchers create artificial cornea using pig and human stem cells

Researchers extracted pig corneal cells and replaced them with human stem cells. Thus, the University of Granada takes the lead in the making of bioartificial organs, a field so far led by the Hospital Gregorio Marañón in Madrid.

15 Apr 2011

Researchers report injectable gel can help treat arthritis

Some 25 million people in the United States alone suffer from rheumatoid arthritis or its cousin osteoarthritis, diseases characterized by often debilitating pain in the joints. Now researchers at Brigham and Women's Hospital report an injectable gel that could spell the future for treating these diseases and others.

15 Apr 2011

New MRI device can make deep brain stimulation effective for patients

A new MRI device that guides surgeons as they implant electrodes into the brains of people with Parkinson's disease and other neurological disorders could change the way this surgery, called deep brain stimulation, is performed at medical centers across the country, according to a group of doctors at University of California, San Francisco.

15 Apr 2011

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S. based Hemispherx Biopharma Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Hemispherx's immune activator in a thirty patient clinical trial.

15 Apr 2011

SQI enters clinical validation agreement with University North Carolina Kidney Center for Vasculitis Assay

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based autoimmune biomarker testing, today announced it entered into a clinical validation agreement with University North Carolina Kidney Center, Chapel Hill, to evaluate SQI's new multiplexed, automated approach for biomarker detection in vasculitis.

15 Apr 2011

Researchers develop sensor film to estimate packaged food quality

When it comes to packaged fish or meat, it is nearly impossible to distinguish between fresh goods and their inedible counterparts. Researchers have now developed a sensor film that can be integrated into the package itself, where it takes over the role of quality control. And if the food has spoiled, it changes color to announce the fact.

15 Apr 2011

Elsevier introduces new online research tool

Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the launch of Methods Navigator. This online research tool enables life scientists to search, access and apply the right method for their research, saving time and producing high-quality results.

15 Apr 2011

NRC, NCKU partner to develop cancer diagnostic and treatment technologies

A Taiwanese research team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University has partnered with a research group led by Dr. Dennis Whitefield from National Research Council of Canada to develop innovative cancer diagnostic and treatment technologies.

15 Apr 2011

Major pharmaceutical company, Access sign deal for RNAi therapeutics

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major pharmaceutical company to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.

15 Apr 2011

Scientists develop new test for premature babies

Scientists at Queen's University Belfast have pioneered a new needle-free test to take the sting out of medicine testing in premature babies. The research will not only lead to greater accuracy in prescribing, but will also significantly reduce the trauma of such tests for newborn infants and their families.

15 Apr 2011

Neurovasx receives FDA approval for cPAX Aneurysm Treatment System

The U.S. Food and Drug Administration has approved the cPAX Aneurysm Treatment System for surgery on brain aneurysms that are difficult to manage because of their size and shape.

15 Apr 2011

Trial of non-invasive prenatal test to determine Down syndrome successful

At the moment, the only reliable way of diagnosing chromosomal irregularities during pregnancy is to use invasive prenatal methods. This causes miscarriage in about one per cent of these risky surgical procedures.

14 Apr 2011

Robotic prostatectomy speeds recovery

Robotic cancer surgery is being introduced into the public hospital system for the first time in Victoria. The Peter MacCallum Cancer Centre in Melbourne has been trialing the robotic key-hole surgery technology for the past six months.

12 Apr 2011

Study finds SAVI applicator for breast brachytherapy safe for women with breast implants

The SAVI® applicator for breast brachytherapy was used to safely deliver post-lumpectomy radiation therapy to a woman with breast implants, according to a newly published paper in a peer-reviewed journal. The case study showed that SAVI produced an "optimal" clinical outcome and "excellent cosmetic results that pleased the patient," wrote the authors.

12 Apr 2011

Lanx launches Concero Facet Screw System at AANS 2011

Lanx, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the launch of the Concero™ Facet Screw System (Concero) at the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, Denver, CO.

12 Apr 2011

Simulations Plus announces release of MedChem Studio 2.0

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today the release of MedChem Studio™ version 2.0 with an impressive set of expanded and powerful capabilities for data mining and de novo molecule design.

12 Apr 2011

Echo awarded method patent for Symphony transdermal continuous glucose monitoring system

Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.

12 Apr 2011

Lanx announces initial launch of Durango Stand-Alone ALIF System

Lanx®, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the initial launch of its Durango™ Stand-Alone ALIF System (Durango), following 510(k) clearance in February. The announcement was made at the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, Denver, CO.

12 Apr 2011